Biochemical and strain properties of CJD prions: Complexity versus simplicity

Journal of Neurochemistry

Volumn 119, Issue 2, 2011, Pages 251-261

  Haïk, Stéphane ^a,b,c,d,e   Brandel, Jean Philippe ^a,b,c,d,e  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Centre National de Référence des Agents Transmissibles Non Conventionnels   (France)

Author keywords

Creutzfeldt Jakob; prion; PrP; strain; transmissible spongiform encephalopathy

Indexed keywords

PRION PROTEIN;

CODON; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; DNA POLYMORPHISM; GENE; GENE OVEREXPRESSION; GENE TARGETING; GENOTYPE; HOMOZYGOSITY; HUMAN; NONHUMAN; PATHOGENESIS; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PRP GENE; REVIEW; SOMATIC MUTATION; VIRUS STRAIN;

ANIMALS; CATTLE; CODON; CREUTZFELDT-JAKOB SYNDROME; EPIDEMICS; GENETIC VARIATION; HUMANS; PRIONS; PROTEIN STRUCTURE, SECONDARY; PRPC PROTEINS; PRPSC PROTEINS;

ANIMALIA; BOVINAE; SCRAPIE PRION;

EID: 80053566142     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07399.x     Document Type: Review

References (116)

1. Aguzzi A., (2009) Cell biology: beyond the prion principle. Nature 459, 924-925.
2. Asante E. A., Linehan J. M., Desbruslais M., et al. (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21, 6358-6366. (Pubitemid 35448414)
3. Beringue V., Le Dur A., Tixador P., et al. (2008) Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS ONE 3, e1419.
4. Bessen R. A., Kocisko D. A., Raymond G. J., Nandan S., Lansbury P. T., and, Caughey B., (1995) Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 375, 698-700.
5. Bishop M. T., Hart P., Aitchison L., et al. (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 5, 393-398.
6. Bishop M. T., Will R. G., and, Manson J. C., (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc. Natl. Acad. Sci. USA 107, 12005-12010.
7. Brandel J. P., Preece M., Brown P., Croes E., Laplanche J. L., Agid Y., Will R., and, Alperovitch A., (2003) Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362, 128-130. (Pubitemid 36831026)
8. Brandel J. P., Heath C. A., Head M. W., et al. (2009) Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann. Neurol. 65, 249-256.
9. Brandel J. P., Galanaud D., Freeman L., Laplanche J. L., and, Haik S., (2010) Variant or sporadic Creutzfeldt-Jakob disease? Lancet 375, 889; author reply 889-890.
10. Brandner S., (2011) Diversity of prion diseases: (no) strains attached? Acta Neuropathol. 121, 1-4.
11. Brandner S., Isenmann S., Raeber A., Fischer M., Sailer A., Kobayashi Y., Marino S., Weissmann C., and, Aguzzi A., (1996) Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343. (Pubitemid 26033075)
12. Brown P., Brandel J. P., Preece M., and, Sato T., (2006) Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 67, 389-393. (Pubitemid 44214958)
13. Bruce M. E., Dickinson A. G., and, Fraser H., (1976) Cerebral amyloidosis in scrapie in the mouse: effect of agent strain and mouse genotype. Neuropathol. Appl. Neurobiol. 2, 471-478. (Pubitemid 8011708)
14. Bruce M. E., Will R. G., Ironside J. W., et al. (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501. (Pubitemid 27435325)
15. Bruce M. E., McConnell I., Will R. G., and, Ironside J. W., (2001) Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 358, 208-209. (Pubitemid 32718547)
16. Büeler H., Aguzzi A., Sailer A., Greiner R. A., Autenried P., Aguet M., and, Weissmann C., (1993) Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347. (Pubitemid 23201147)
17. Cali I., Castellani R., Alshekhlee A., et al. (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132, 2643-2658.
18. Casalone C., Zanusso G., Acutis P., Ferrari S., Capucci L., Tagliavini F., Monaco S., and, Caramelli M., (2004) Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. USA 101, 3065-3070. (Pubitemid 38327735)
19. Castilla J., Saa P., Hetz C., and, Soto C., (2005) In vitro generation of infectious scrapie prions. Cell 121, 195-206. (Pubitemid 40546388)
20. Castilla J., Gonzalez-Romero D., Saa P., Morales R., De Castro J., and, Soto C., (2008a) Crossing the species barrier by PrP(Sc) replication in vitro generates unique infectious prions. Cell 134, 757-768.
21. Castilla J., Morales R., Saa P., Barria M., Gambetti P., and, Soto C., (2008b) Cell-free propagation of prion strains. EMBO J. 27, 2557-2566.
22. Caughey B., Raymond G. J., and, Bessen R. A., (1998) Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 27, 32230-32235. (Pubitemid 29177169)
23. Clavaguera F., Bolmont T., Crowther R. A., et al. (2009) Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11, 909-913.
24. Collinge J., (1999) Variant Creutzfeldt-Jakob disease. Lancet 354, 317-323. (Pubitemid 29348751)
25. Collinge J., (2010) Medicine prion strain mutation and selection. Science 328, 1111-1112.
26. Collinge J., and, Clarke A. R., (2007) A general model of prion strains and their pathogenicity. Science 318, 930-936. (Pubitemid 350098981)
27. Collinge J., Sidle K. C. L., Meads J., Ironside J., and, Hill A. F., (1996) Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 383, 685-690. (Pubitemid 26360638)
28. Collinge J., Whitfield J., McKintosh E., Beck J., Mead S., Thomas D. J., and, Alpers M. P., (2006) Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 367, 2068-2074. (Pubitemid 43949290)
29. Comoy E. E., Casalone C., Lescoutra-Etchegaray N., et al. (2008) Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS ONE 3, e3017.
30. Cronier S., Beringue V., Bellon A., Peyrin J. M., and, Laude H., (2007) Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures. J. Virol. 81, 13794-13800. (Pubitemid 350247872)
31. Fasano C., Campana V., and, Zurzolo C., (2006) Prions: protein only or something more? Overview of potential prion cofactors J. Mol. Neurosci. 29, 195-214. (Pubitemid 44684495)
32. Faucheux B. A., Privat N., Brandel J. P., Sazdovitch V., Laplanche J. L., Maurage C. A., Hauw J. J., and, Haik S., (2009) Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 68, 892-901.
33. Faucheux B. A., Morain E., Diouron V., et al. (2011) Quantification of surviving cerebellar granule neurones and abnormal prion protein (PrP(Sc)) deposition in sporadic Creutzfeldt-Jakob disease supports a pathogenic role for small PrP(Sc) deposits common to the various molecular subtypes. Neuropathol. Appl. Neurobiol. 37, 500-512.
34. Frost B., Ollesch J., Wille H., and, Diamond M. I., (2009) Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J. Biol. Chem. 284, 3546-3551.
35. Gambetti P., Dong Z., Yuan J., et al. (2008) A novel human disease with abnormal prion protein sensitive to protease. Ann. Neurol. 63, 697-708. (Pubitemid 351945529)
36. Gambetti P., Cali I., Notari S., Kong Q., Zou W. Q., and, Surewicz W. K., (2011) Molecular biology and pathology of prion strains in sporadic human prion diseases. Acta Neuropathol. 121, 79-90.
37. Giles K., Glidden D. V., Beckwith R., Seoanes R., Peretz D., DeArmond S. J., and, Prusiner S. B., (2008) Resistance of bovine spongiform encephalopathy (BSE) prions to inactivation. PLoS Pathog. 4, e1000206.
38. Giles K., Glidden D. V., Patel S., Korth C., Groth D., Lemus A., DeArmond S. J., and, Prusiner S. B., (2010) Human prion strain selection in transgenic mice. Ann. Neurol. 68, 151-161.
39. Haik S., Faucheux B. A., Sazdovitch V., Privat N., Kemeny J. L., Perret-Liaudet A., and, Hauw J. J., (2003) The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nat. Med. 9, 1121-1123. (Pubitemid 37173693)
40. Haik S., Brandel J. P., Salomon D., et al. (2004a) Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects. Neurology 63, 2413-2415. (Pubitemid 40024366)
41. Haik S., Faucheux B. A., and, Hauw J. J., (2004b) Brain targeting through the autonomous nervous system: lessons from prion diseases. Trends Mol. Med. 10, 107-112.
42. Haik S., Peoc'h K., Brandel J. P., Privat N., Laplanche J. L., Faucheux B. A., and, Hauw J. J., (2004c) Striking PrPsc heterogeneity in inherited prion diseases with the D178N mutation. Ann. Neurol. 56, 909-910.
43. Hauw J. J., Sazdovitch V., Laplanche J. L., et al. (2000) Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene. Neurology 54, 1641-1646. (Pubitemid 30226808)
44. Head M. W., Bunn T. J., Bishop M. T., et al. (2004) Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann. Neurol. 55, 851-859. (Pubitemid 38702581)
45. Head M. W., Knight R., Zeidler M., Yull H., Barlow A., and, Ironside J. W., (2009a) A case of protease sensitive prionopathy in a patient in the UK. Neuropathol. Appl. Neurobiol. 35, 628-632.
46. Head M. W., Yull H. M., Ritchie D. L., Bishop M. T., and, Ironside J. W., (2009b) Pathological investigation of the first blood donor and recipient pair linked by transfusion-associated variant Creutzfeldt-Jakob disease transmission. Neuropathol. Appl. Neurobiol. 35, 433-436.
47. Hill A. F., Desbruslais M., Joiner S., Sidle K. C. L., Gowland I., Collinge J., Doey L. J., and, Lantos P., (1997a) The same prion strain causes vCJD and BSE. Nature 389, 448-450. (Pubitemid 27435311)
48. Hill A. F., Zeidler M., Ironside J., and, Collinge J., (1997b) Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349, 99-100. (Pubitemid 27023429)
49. Hill A. F., Joiner S., Wadsworth J. D., Sidle K. C., Bell J. E., Budka H., Ironside J. W., and, Collinge J., (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126, 1333-1346. (Pubitemid 36644379)
50. Hosszu L. L., Jackson G. S., Trevitt C. R., et al. (2004) The residue 129 polymorphism in human prion protein does not confer susceptibility to Creutzfeldt-Jakob disease by altering the structure or global stability of PrPC. J. Biol. Chem. 279, 28515-28521. (Pubitemid 38900134)
51. Ironside J. W., Bishop M. T., Connolly K., Hegazy D., Lowrie S., Le Grice M., Ritchie D. L., McCardle L. M., and, Hilton D. A., (2006) Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 332, 1186-1188. (Pubitemid 44365449)
52. Jansen C., Head M. W., van Gool W. A., Baas F., Yull H., Ironside J. W., and, Rozemuller A. J., (2010) The first case of protease-sensitive prionopathy (PSPr) in the Netherlands: a patient with an unusual GSS-like clinical phenotype. J. Neurol. Neurosurg. Psychiatry 81, 1052-1055.
53. Jones M., Peden A. H., Prowse C. V., Groner A., Manson J. C., Turner M. L., Ironside J. W., MacGregor I. R., and, Head M. W., (2007) In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J. Pathol. 213, 21-26. (Pubitemid 47354562)
54. Jones M., Peden A. H., Wight D., Prowse C., Macgregor I., Manson J., Turner M., Ironside J. W., and, Head M. W., (2008) Effects of human PrPSc type and PRNP genotype in an in-vitro conversion assay. Neuroreport 19, 1783-1786.
55. Jones M., Wight D., Barron R., Jeffrey M., Manson J., Prowse C., Ironside J. W., and, Head M. W., (2009) Molecular model of prion transmission to humans. Emerg. Infect. Dis. 15, 2013-2016.
56. Kaneko K., Zulianello L., Scott M., Cooper C. M., Wallace A. C., James T. L., Cohen F. E., and, Prusiner S. B., (1997) Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. USA 94, 10069-10074.
57. Kaski D., Mead S., Hyare H., Cooper S., Jampana R., Overell J., Knight R., Collinge J., and, Rudge P., (2009) Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 374, 2128.
58. Kawauchi Y., Kamitani T., Yagishita S., Kitamoto T., and, Kishida H., (2006) Autopsy case of Creutzfeldt-Jakob disease with Met/Val heterozygosity at codon 129 and type 1 protease-resistant prion protein presenting some florid-type plaques and many Kuru plaques in the cerebellum. Neuropathology 26, 313-317. (Pubitemid 44086834)
59. Kobayashi A., Asano M., Mohri S., and, Kitamoto T., (2007) Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain. J. Biol. Chem. 282, 30022-30028. (Pubitemid 350035250)
60. Kobayashi A., Arima K., Ogawa M., Murata M., Fukuda T., and, Kitamoto T., (2008) Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients. Acta Neuropathol. 116, 561-566.
61. Kobayashi A., Sakuma N., Matsuura Y., Mohri S., Aguzzi A., and, Kitamoto T., (2010) Experimental verification of a traceback phenomenon in prion infection. J. Virol. 84, 3230-3238.
62. Kong Q., Zheng M., Casalone C., et al. (2008) Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J. Virol. 82, 3697-3701. (Pubitemid 351429945)
63. Korth C., Kaneko K., Groth D., et al. (2003) Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc. Natl. Acad. Sci. USA 100, 4784-4789. (Pubitemid 36457806)
64. Kovacs G. G., Puopolo M., Ladogana A., et al. (2005) Genetic prion disease: the EUROCJD experience. Hum. Genet. 118, 166-174. (Pubitemid 41672078)
65. Kretzschmar H. A., Prusiner S. B., Stowring L. E., and, DeArmond S. J., (1986) Scrapie prion proteins are synthesized in neurons. Am. J. Pathol. 122, 1-5. (Pubitemid 16108541)
66. Laffont-Proust I., Faucheux B. A., Hassig R., Sazdovitch V., Simon S., Grassi J., Hauw J. J., Moya K. L., and, Haik S., (2005) The N-terminal cleavage of cellular prion protein in the human brain. FEBS Lett. 579, 6333-6337. (Pubitemid 41612148)
67. Laffont-Proust I., Hassig R., Haik S., Simon S., Grassi J., Fonta C., Faucheux B. A., and, Moya K. L., (2006) Truncated PrP(c) in mammalian brain: interspecies variation and location in membrane rafts. Biol. Chem. 387, 297-300.
68. Lasmezas C. I., Comoy E., Hawkins S., et al. (2005) Risk of oral infection with bovine spongiform encephalopathy agent in primates. Lancet 365, 781-783. (Pubitemid 40311365)
69. Lasmézas C. I., Deslys J. P., Demaimay R., Adjou K. T., Lamoury F., Dormont D., Robain O., Ironside J., and, Hauw J. J., (1996) BSE transmission to macaques. Nature 381, 743-744.
70. Lee S., Antony L., Hartmann R., Knaus K. J., Surewicz K., Surewicz W. K., and, Yee V. C., (2010) Conformational diversity in prion protein variants influences intermolecular beta-sheet formation. EMBO J. 29, 251-262.
71. Levavasseur E., Laffont-Proust I., Morain E., et al. (2008) Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease - implications for the dissemination and the diagnosis of human prion strains. PLoS ONE 3, e2786.
72. Li J. Y., Englund E., Holton J. L., et al. (2008) Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 14, 501-503. (Pubitemid 351655211)
73. Llewelyn C. A., Hewitt P. E., Knight R. S., Amar K., Cousens S., Mackenzie J., and, Will R. G., (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 417-421. (Pubitemid 38210057)
74. Lo R. Y., Shyu W. C., and, Li H., (2006) Long-duration sCJD with PRNP codon 129 methionine homozygosity and cerebral cortical plaques. Neurology 66, 1944-1945. (Pubitemid 44049837)
75. Mallucci G., Dickinson A., Linehan J., Klohn P. C., Brandner S., and, Collinge J., (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874. (Pubitemid 37339628)
76. Meyer-Luehmann M., Coomaraswamy J., Bolmont T., et al. (2006) Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host. Science 313, 1781-1784. (Pubitemid 44454153)
77. Minor P., Newham J., Jones N., et al. (2004) Standards for the assay of Creutzfeldt-Jakob disease specimens. J. Gen. Virol. 85, 1777-1784. (Pubitemid 38807775)
78. Morales R., Abid K., and, Soto C., (2007) The prion strain phenomenon: molecular basis and unprecedented features. Biochim. Biophys. Acta 1772, 681-691. (Pubitemid 46887653)
79. Moser M., Colello R. J., Pott U., and, Oesch B., (1995) Developmental expression of the prion protein gene in glial cells. Neuron 14, 509-517.
80. Nonno R., Bari M. A., Cardone F., et al. (2006) Efficient transmission and characterization of creutzfeldt-jakob disease strains in bank voles. PLoS Pathog. 2, e12.
81. Notari S., Capellari S., Giese A., Westner I., Baruzzi A., Ghetti B., Gambetti P., Kretzschmar H. A., and, Parchi P., (2004) Effects of different experimental conditions on the PrPSc core generated by protease digestion: implications for strain typing and molecular classification of CJD. J. Biol. Chem. 279, 16797-16804. (Pubitemid 38509382)
82. Notari S., Strammiello R., Capellari S., et al. (2008) Characterization of truncated forms of abnormal prion protein in Creutzfeldt-Jakob disease. J. Biol. Chem. 283, 30557-30565.
83. Olanow C. W., and, Prusiner S. B., (2009) Is Parkinson's disease a prion disorder? Proc. Natl. Acad. Sci. USA 106, 12571-12572.
84. Parchi P., Castellani R., Capellari S., et al. (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 39, 767-778. (Pubitemid 26183813)
85. Parchi P., Capellari S., Chen S. G., et al. (1997) Typing prion isoforms. Nature 386, 232-233.
86. Parchi P., Giese A., Capellari S., et al. (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 46, 224-233. (Pubitemid 29382879)
87. Parchi P., Zou W., Wang W., et al. (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc. Natl. Acad. Sci. USA 97, 10168-10172.
88. Parchi P., Notari S., Weber P., et al. (2009a) Inter-laboratory assessment of PrP(Sc) typing in Creutzfeldt-Jakob disease: a western blot study within the NeuroPrion Consortium. Brain Pathol. 9, 384-391.
89. Parchi P., Strammiello R., Notari S., et al. (2009b) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol. 118, 659-671.
90. Parchi P., Cescatti M., Notari S., et al. (2010) Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 133, 3030-3042.
91. Parchi P., Strammiello R., Giese A., and, Kretzschmar H., (2011) Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol. 121, 91-112.
92. Peden A. H., Head M. W., Ritchie D. L., Bell J. E., and, Ironside J. W., (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529. (Pubitemid 39070413)
93. Prusiner S. B., (1998) Prions. Proc. Natl. Acad. Sci. USA 95, 13363-13383. (Pubitemid 28525623)
94. Puoti G., Giaccone G., Rossi G., Canciani B., Bugiani O., and, Tagliavini F., (1999) Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 53, 2173-2176.
95. Saa P., Castilla J., and, Soto C., (2006) Presymptomatic detection of prions in blood. Science 313, 92-94. (Pubitemid 44051260)
96. Saborio G. P., Permanne B., and, Soto C., (2001) Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813. (Pubitemid 32588105)
97. Schoch G., Seeger H., Bogousslavsky J., Tolnay M., Janzer R. C., Aguzzi A., and, Glatzel M., (2006) Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med. 3, e14.
98. Scott M. R., Will R., Ironside J., Nguyen H. O., Tremblay P., DeArmond S. J., and, Prusiner S. B., (1999) Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc. Natl. Acad. Sci. USA 96, 15137-15142. (Pubitemid 30019778)
99. Scott M. R., Supattapone S., Nguyen H. O., DeArmond S. J., and, Prusiner S. B., (2000) Transgenic models of prion disease. Arch. Virol. Suppl. 16, 113-124. (Pubitemid 33757370)
100. Sim V. L., and, Caughey B., (2009) Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol. Aging 30, 2031-2042.
101. Taguchi Y., Mohri S., Ironside J. W., Muramoto T., and, Kitamoto T., (2003) Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions. Am. J. Pathol. 163, 2585-2593. (Pubitemid 37466499)
102. Telling G. C., Foster D., Yang S. L., DeArmond S. J., and, Prusiner S. B., (1995) Transgenic mice expressing human and chimeric human-mouse prion proteins carrying the codon 102 mutation of GSS, in 47ème meeting annuel de l'académie américaine de Neurologie (A. a. o. Neurology ed.), Vol. 45, pp. 521. P. Neurology, Seattle, Washington.
103. Telling G. C., Parchi P., Dearmond S. J., et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274, 2079-2082. (Pubitemid 27020700)
104. Thomzig A., Spassov S., Friedrich M., Naumann D., and, Beekes M., (2004) Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J. Biol. Chem. 279, 33847-33854. (Pubitemid 39063034)
105. Tixador P., Herzog L., Reine F., Jaumain E., Chapuis J., Le Dur A., Laude H., and, Beringue V., (2010) The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog. 6, e1000859.
106. Uro-Coste E., Cassard H., Simon S., et al. (2008) Beyond PrP9res) type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog. 4, e1000029.
107. Wadsworth J. D., Asante E. A., Desbruslais M., et al. (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306, 1793-1796. (Pubitemid 39601400)
108. Ward H. J., Everington D., Cousens S. N., et al. (2006) Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann. Neurol. 59, 111-120. (Pubitemid 43042877)
109. Weissmann C., (2004) The state of the prion. Nat. Rev. Microbiol. 2, 861-871. (Pubitemid 39561804)
110. Will R. G., Ironside J. W., Zeidler M., et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925. (Pubitemid 26102546)
111. Wroe S. J., Pal S., Siddique D., et al. (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368, 2061-2067. (Pubitemid 44855106)
112. Yull H. M., Ritchie D. L., Langeveld J. P., van Zijderveld F. G., Bruce M. E., Ironside J. W., and, Head M. W., (2006) Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am. J. Pathol. 168, 151-157. (Pubitemid 43062568)
113. Zahn R., Liu A., Luhrs T., et al. (2000) NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. USA 97, 145-150. (Pubitemid 30055798)
114. Zanusso G., Farinazzo A., Prelli F., et al. (2004) Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes. J. Biol. Chem. 279, 38936-38942. (Pubitemid 39296054)
115. Zanusso G., Polo A., Farinazzo A., et al. (2007) Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease. Arch. Neurol. 64, 595-599. (Pubitemid 46588352)
116. Zou W. Q., Puoti G., Xiao X., et al. (2010) Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann. Neurol. 68, 162-172.